Common mutation types in lung adenocarcinoma include epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK) rearranged, and C-ros oncogene 1-receptor tyrosine kinase (ROS1) fusion (1). This evidence concerns the gene ALK and lung adenocarcinoma.